1.95
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
2.59%
23.17
|
22.58 | 26.94 | 26.50 | 21.53 |
Operating Income/Loss |
2.59%
-23.17
|
-22.58 | -26.94 | -26.50 | -21.53 |
Nonoperating Income/Loss |
1,048%
-2.929
|
0.309 | -3.945 | 2.698 | 1.221 |
Income/Loss From Continuing Operations Before Tax |
17.17%
-26.10
|
-22.27 | -30.89 | -23.81 | -20.31 |
Income Tax Expense/Benefit |
19.18%
0.118
|
0.146 | 0.445 | 0.209 | 0.374 |
Income/Loss From Continuing Operations After Tax |
16.93%
-26.22
|
-22.42 | -31.33 | -24.02 | -20.69 |
|
16.93%
-26.22
|
-22.42 | -31.33 | -24.02 | -20.69 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
65.88
|
65.88 | - | 65.88 | 65.88 |
Diluted Average Shares |
0.00%
65.88
|
65.88 | - | 65.88 | 65.88 |
Basic Earnings Per Share |
17.65%
-0.40
|
-0.34 | -0.48 | -0.36 | -0.31 |
Diluted Earnings Per Share |
17.65%
-0.40
|
-0.34 | -0.48 | -0.36 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):